BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26779994)

  • 1. A case of amylase-producing small cell lung cancer.
    Wang H; Wu Q
    Clin Biochem; 2016 May; 49(7-8):613-6. PubMed ID: 26779994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer?
    Yanagitani N; Kaira K; Sunaga N; Naito Y; Koike Y; Ishihara S; Ishizuka T; Saito R; Mori M
    Int J Clin Oncol; 2007 Jun; 12(3):231-3. PubMed ID: 17566849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of amylase-producing lung cancer.
    Tsukawaki M; Izawa M; Yoshida M; Araki N; Hashiba Y; Nakagawa H; Momose M; Kawase S; Tominaga J; Kawai S
    Intern Med; 1992 Jan; 31(1):60-3. PubMed ID: 1373662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report.
    Casadei Gardini A; Mariotti M; Lucchesi A; Pini S; Valgiusti M; Bravaccini S; Del Monte A; Burgio MA; Marisi G; Amadori D; Frassineti GL
    BMC Cancer; 2016 Feb; 16():118. PubMed ID: 26887807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good response to gefitinib for lung adenocarcinoma with hyperamylasemia: a case report.
    Ko HW; Tsai YH; Yu CT; Huang CY; Chen CH
    Chang Gung Med J; 2008; 31(6):606-11. PubMed ID: 19241901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of amylase-producing lung cancer].
    Minami S; Komuta K; Asai M
    Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):717-21. PubMed ID: 14584392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of amylase producing lung cancer].
    Kitazawa M; Nakagawa M; Baba O; Sumiyoshi K; Saito Y; Nishimura T; Bamba T; Hosoda S
    Kokyu To Junkan; 1993 Apr; 41(4):393-6. PubMed ID: 7685922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The First Case of Pulmonary Alveolar Proteinosis With Small Cell Lung Carcinoma.
    Hiraki T; Goto Y; Kitazono I; Tasaki T; Higashi M; Hatanaka K; Tanimoto A
    Int J Surg Pathol; 2016 Apr; 24(2):135-8. PubMed ID: 26519525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early postoperative hyperamylasemia after parathyroidectomy for primary hyperparathyroidism].
    Solis-Caxaj CA; Jafari M; Latteux C; Galleri D; Pattou F; Carnaille B; Franceschi A; Proye C
    Ann Chir; 2004 Jun; 129(5):269-72. PubMed ID: 15220099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperamylasemia in endometrial adenocarcinoma].
    Matsuta M; Murakami K; Ono H; Saitoh S; Nishiya I; Takayama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1557-64. PubMed ID: 2479698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked hyperamylasemia associated with carcinoma of the lung.
    Flood JG; Schuerch C; Dorazio RC; Bowers GN
    Clin Chem; 1978 Jul; 24(7):1207-12. PubMed ID: 207468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of amylase isoenzyme determination for the diagnosis of pancreatic diseases].
    Otsuki M
    Nihon Rinsho; 1995 May; 53(5):1184-91. PubMed ID: 7541479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperamylasemia, laboratory and clinical aspects].
    Kocna P; Zima T
    Cas Lek Cesk; 2006; 145(6):449-52. PubMed ID: 16835996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenging problems in malignancy: case 1. Presentation of small-cell lung cancer with marked hyperamylasemia.
    Benedetti G; Rastelli F; Damiani S; Calandri C; Crinò L
    J Clin Oncol; 2004 Sep; 22(18):3826-8. PubMed ID: 15365080
    [No Abstract]   [Full Text] [Related]  

  • 15. Massive liver necrosis associated with hyperamylasemia.
    Galus M; Schiffman R; Olkowska D
    Liver; 1998 Jun; 18(3):205-7. PubMed ID: 9716232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonspecific hyperamylasemia: a case report.
    Wiederkehr JC; Wiederkehr BA; Wiederkehr HA; Carvalho CA
    JOP; 2013 Jan; 14(1):74-6. PubMed ID: 23306339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer.
    Togashi Y; Masago K; Handa T; Tanizawa K; Okuda C; Sakamori Y; Nagai H; Kim YH; Mishima M
    Clin Lung Cancer; 2012 Jul; 13(4):304-11. PubMed ID: 22169479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amylase-producing lung cancer: case report and review of the literature.
    Katayama S; Ikeuchi M; Kanazawa Y; Akanuma Y; Kosaka K; Takeuchi T; Nakayama T
    Cancer; 1981 Dec; 48(11):2499-502. PubMed ID: 6170423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
    Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
    Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecan.
    Tiseo M; Buti S; Boni L; Mattioni R; Ardizzoni A
    Lung Cancer; 2014 Oct; 86(1):91-5. PubMed ID: 25130081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.